UMECLIDINIUM

Trade Name: Incruse Ellipta
Classification: LAMA
Dose: 62.5mcg
Modality: DPI
Indication: Maintenance treatment for COPD.
Contraindication: Hypersensitivity to any ingredient
Side Effect: Cough

Good luck with your studies!